Stock Price & Analysis

Based on the provided data and current market context, I'll analyze whether to buy or sell KMB stock.

Technical Analysis

The stock is showing mixed signals with recent price action:

• Currently trading at $117.35 (as of Feb 23, 2025)
• Has formed an upward trend over the past week, gaining about 2.8%
• RSI reading of 71.83 indicates overbought conditions
• Trading above both 5-day and 10-day moving averages, suggesting short-term momentum

Fundamental Analysis

Key metrics show:

• Revenue declined 3.51% in recent quarter
• Net margin of 18.32% exceeds industry average
• Strong ROE of 74.93%
• Healthy debt management with debt-to-equity ratio of 5.8

Analyst Sentiment

Recent analyst consensus:

• Hold rating from 15 analysts
• Average price target of $143.64 (2.40% upside potential)
• 2 Sell, 8 Hold, 5 Buy ratings
• Price targets range from $118 to $165

Insider Activity

• Notable insider selling of $5.3M worth of shares in recent months
• Chief Business & Transformation Officer sold shares at $136 level
• Insider selling could signal potential weakness ahead

Based on the technical overbought conditions, mixed analyst sentiment, and recent insider selling activity, the recommendation is to SELL KMB stock at current levels. Consider re-entering at lower support levels around $131-132.

Based on the provided data and recent analyst reports, here's a concise 3-sentence price prediction for KMB stock in 2025:

KMB stock is projected to reach $147.57 by end of 2025, supported by analyst consensus targets ranging from $130 to $165, though growth limitations and market challenges could impact this target. The company's strong net margin of 18.32% and impressive ROE of 74.93% provide fundamental support for this price target, while technical indicators showing RSI recently entering oversold territory at 27.8 suggest potential upward momentum. However, lack of revenue growth (-3.51% decline) and broader market challenges in the consumer staples sector may limit significant upside beyond this target.

The S1 support level for KMB Stock is $133.19 ,The R1 resistant level for KMB Stock is $141.87.

As of the end of day on 2025-02-27, the price of KMB Stock was $140.95.

The target price for KMB Stock according to analyst rating is 145.50, with the highest price target at 168.00 and the lowest at 124.00. Analysts have a Hold rating on KMB Stock overall.

The market cap of KMB is $46.5B.

Based on the provided data, here's a concise analysis of KMB's valuation:

Valuation Analysis: KMB's current P/E ratio of 23.34 and EV/EBITDA of 12.97 suggest moderate overvaluation compared to historical levels. The stock's P/S ratio of 2.01 and P/B ratio of 44.75 also indicate premium pricing relative to fundamentals.

Technical Indicators: The stock is showing overbought signals with RSI at 71.83 and stochastic RSI at 100, while trading above both its 20-day (132.35) and 200-day (135.40) moving averages. The current price of $140.59 is testing the upper Bollinger Band at 142.78.

Financial Performance: Net income declined from $1.93B in 2022 to $1.76B in 2023, while net margin decreased from 9.72% to 8.63%. Despite revenue growth of 1.27% YoY, profitability metrics show deterioration.

Market Sentiment: Recent analyst coverage shows mixed sentiment, with price targets ranging from $130 to $165, averaging $147.57. The stock offers a 3.88% dividend yield, which is attractive but may not fully compensate for the current valuation premium.

Conclusion: Yes, KMB appears overvalued at current levels due to declining profitability metrics, premium valuation multiples, and overbought technical indicators. The stock's defensive nature and dividend yield may justify some premium, but current prices exceed fundamental support.

Kimberly-Clark Corporation is principally engaged in the manufacturing and marketing of a range of products made from natural or synthetic fibers and materials using advanced technologies in fibers, nonwovens and absorbency. The Company has three segments. Personal Care segment offer solutions and products, such as disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear and other related products. Products in this segment are sold under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex and other brand names. Consumer Tissue segment offers facial and bathroom tissue, paper towels, napkins and related products, and are sold under the Kleenex, Scott, Cottonelle, Andrex, Viva, Scottex and other brand names. K-C Professional segment offers wipers, tissue, towels, personal protective equipment, soaps and sanitizers under the Kleenex, Scott, WypAll, Kimtech and KleenGuard brand name.

Based on the provided data and context, I'll analyze KMB's price prediction for 2030 in three concise sentences:

Kimberly-Clark (KMB) is likely to reach $165-170 by 2030, driven by its strong market position in essential consumer products and consistent dividend growth history, though facing moderate growth challenges as indicated by recent analyst projections. The company's solid fundamentals, including an impressive ROE of 74.93% and net margin of 18.32%, combined with its strategic focus on premium products and emerging markets, support this long-term price target despite near-term headwinds in revenue growth (-3.51%). However, the recent oversold RSI reading of 27.8 and analysts' current average price target of $147.57 suggest potential volatility in the path to this 2030 target.

KMB has a total of 41000 employees.